Evidence map›Paper›PMID 42395676›Full record

ArticleWorld journal of nephrology2026

Is the metabolic dysfunction-associated steatotic liver disease a predictor of chronic kidney disease?

Nashwa M Azoz, Marwa A Shehata, Wael A Abbas, Rabea A Gadelkareem, Essam M Abdel Aziz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nashwa M AzozDepartment of Internal Medicine-Nephrology Unit, Assiut University Hospital, Faculty of Medicine, Assiut University, Assiut 71711, Egypt.
Marwa A ShehataDepartment of Internal Medicine-Endocrinology Unit, Assiut University Hospital, Faculty of Medicine, Assiut University, Assiut 71711, Egypt.
Wael A AbbasDepartment of Internal Medicine-Gastroenterology Unit, Faculty of Medicine, Assuit University, Assuit 71511, Egypt.
Rabea A GadelkareemDepartment of Urology, Assiut Urology and Nephrology Hospital, Faculty of Medicine, Assiut University, Assiut 71515, Egypt. rabeagad@aun.edu.eg.
Essam M Abdel AzizDepartment of Internal Medicine-Nephrology Unit, Assiut University Hospital, Faculty of Medicine, Assiut University, Assiut 71711, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem disorder strongly associated with metabolic dysfunction. Emerging evidence suggests a close association between MASLD and chronic kidney disease (CKD). However, the magnitude and determinants of renal involvement remain inconsistent across studies, particularly in relation to diabetes mellitus (DM) and hepatic fibrosis.

aimTo assess the association between CKD and MASLD and identify the predictors of renal impairment in patients with MASLD.

methodsA case-control study was conducted in the Internal Medicine Department, Faculty of Medicine, Assiut University, Egypt, between March 2024 and March 2025. It included 150 participants recruited from outpatient clinics. Participants were divided into three groups: Those with MASLD and type 2 DM (

resultsThe three groups were similar in terms of mean age (

conclusionMASLD is associated with CKD, particularly in patients with DM and advanced hepatic fibrosis. Incorporating non-invasive liver fibrosis assessment may aid in the early identification of patients with MASLD who are at a high risk of renal disease.

Indexed as

Chronic kidney diseaseDiabetes mellitusHepatic fibrosisKidney injuryMetabolic dysfunction-associated steatotic liver diseaseObesity

Identifiers

PMID42395676
PMCPMC13324396

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.